Analyst firms · Barclays · PODD

Barclays PODD price target and rating history

Insulet Corporation (PODD) · Health Care

Barclays rates Insulet Corporation (PODD) Equal Weight with a $150 price target, as of its latest action on Oct 7, 2026. It has published 3 rating actions on PODD since October 2022, including 0 upgrades and 1 downgrade. Across 10 firms with a PODD price target in the last 12 months, the median target is $182. Barclays's $150 is 18% below that.

Current rating

Equal Weight

Price target

$150

Median target, all firms

$182

Actions on PODD

3

Barclays price target on PODD

Every Barclays rating on PODD

• Oct 7, 2026
  InitiateBarclays starts coverage at Equal Weight, price target $150
• Jan 12, 2026
  DowngradeBarclays downgrades to Equal Weight from Overweight, price target $274
• Oct 18, 2022
  InitiateBarclays starts coverage at Equal Weight, price target $238

How other firms rate PODD

Each firm's latest rating and stated target in the last 12 months.

Questions about Barclays and PODD

What is Barclays's price target for PODD?

Barclays's latest stated price target for Insulet Corporation (PODD) is $150, from its action on Oct 7, 2026.

What is Barclays's rating on PODD?

Barclays rates PODD Equal Weight, a neutral rating, as of Oct 7, 2026.

When did Barclays last change its view on PODD?

On Oct 7, 2026, Barclays starts coverage at Equal Weight, price target $150.

How does Barclays's PODD target compare with other analysts?

Across 10 firms with a PODD price target in the last 12 months, the median target is $182. Barclays's $150 is 18% below that.

More PODD rating histories

• Leerink Partners4
• Oppenheimer3
• UBS3
• Citigroup3
• Wolfe Research4
• Morgan Stanley5

All Barclays ratingsPODD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.